In fact, while several studies, including the largest analysis performed in pediatric cases [36], failed to document any significant effect of RAS mutations on survival, a recent paper focusing on MLL-rearranged infant ALL documented an independent prognostic factor of NRAS/KRAS [33, 35, 36]. The gene discussed is KRAS; the disease is acute lymphoblastic leukemia.